Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$6.6M
-45.8% from 2023
Prescriptions
6,166
$1,063.86 per claim
Patients
958
1,015 prescribers
Total spending, 2024
$6.6M
$6,847.33 per patient
Medicare prescription drug plans paid $6.6M for Erlotinib Hcl in 2024, for 6,166 prescriptions and refills to 958 patients (down 45.8% from 2023). The average cost per claim was $1,063.86.
New York had the highest Medicare cost for Erlotinib Hcl in 2024: $1.1M for 655 claims, followed by California ($832K).
Mark B Stoopler, medical oncology in New York, NY, had the highest Medicare cost for Erlotinib Hcl in 2024: 40 claims costing $157K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Mark B Stoopler New York, NY | Medical Oncology | 40 | Under 11 | $157K |
| Natalia Cherkassky Fair Lawn, NJ | Nurse Practitioner | 41 | Under 11 | $112K |
| Kevin M Sullivan |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 1,176 | 7,088 | 1,137 | $16.3M |
| 2023 | 991 | 6,145 | 952 | $12.1M |
| 2024 | 1,015 | 6,166 | 958 | $6.6M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 16 |
| Under 11 |
| $92K |
| Yasir Elamin Houston, TX | Medical Oncology | 18 | Under 11 | $84K |
| Helena Yu New York, NY | Medical Oncology | 35 | Under 11 | $79K |
| Maen A Hussein Lady Lake, FL | Hematology-Oncology | 12 | Under 11 | $77K |
| Rafid J Kouz Mission Hills, CA | Hematology-Oncology | 11 | Under 11 | $67K |
| Judy Y Pagtama Stanford, CA | Nurse Practitioner | 16 | Under 11 | $66K |
| Michael B Wax Berkeley Heights, NJ | Medical Oncology | 11 | Under 11 | $62K |
| Adam J Goldrich Annapolis, MD | Hematology-Oncology | 16 | Under 11 | $56K |
| Richard Gralla New Hyde Park, NY | Internal Medicine | 11 | Under 11 | $54K |
| Caitlin C Meservey Ann Arbor, MI | Physician Assistant | 28 | Under 11 | $53K |
| Andy Y Huang Brooklyn, NY | Hematology | 20 | Under 11 | $52K |
| Lea Robichaud Weymouth, MA | Nurse Practitioner | 12 | Under 11 | $52K |
| Myron E Bednar Flemington, NJ | Hematology | 12 | Under 11 | $51K |
| Mohammad P Rahman Steubenville, OH | Medical Oncology | 14 | Under 11 | $51K |
| Dhivya Prabhakar Newnan, GA | Internal Medicine | 22 | Under 11 | $51K |
| Paul Paik New York, NY | Medical Oncology | 25 | Under 11 | $51K |
| Jonathan E Dowell Dallas, TX | Hematology-Oncology | 18 | Under 11 | $49K |
| Isam A Abdel-Karim Fort Smith, AR | Hematology-Oncology | 12 | Under 11 | $48K |
| Omer Khalil Little Rock, AR | Hematology-Oncology | 11 | Under 11 | $48K |
| Alvaro Pereira-Rico Philadelphia, PA | Hematology-Oncology | 11 | Under 11 | $47K |
| Eli Kirshner Westwood, NJ | Hematology-Oncology | 12 | Under 11 | $46K |
| Joseph I Levine Duluth, MN | Medical Oncology | 14 | Under 11 | $45K |
| Nayana R Kamath Rochester, NY | Medical Oncology | 12 | Under 11 | $44K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Zydus Pharmaceu ZYDUSLIFE.NS | 3,086 | $3.3M |
| Novadoz Pharmac | 836 | $1.3M |
| Teva USA TEVA | 1,216 | $976K |
| Alembic Pharmac | 806 | $703K |
| Sun Pharmaceuti SUNPHARMA.NS | 136 | $204K |
| Breckenridge | 86 | $65K |